| Primary |
| Product Used For Unknown Indication |
23.0% |
| Hypertension |
12.3% |
| Plastic Surgery |
9.8% |
| Haemangioma |
7.4% |
| Migraine |
6.1% |
| Anaesthesia |
4.9% |
| Sedation |
4.9% |
| Pain |
4.5% |
| Anxiety |
3.7% |
| Drug Exposure During Pregnancy |
3.7% |
| Supraventricular Tachycardia |
3.7% |
| Pain Prophylaxis |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Depression |
2.0% |
| Drug Use For Unknown Indication |
1.6% |
| Hepatic Cirrhosis |
1.6% |
| Renal Cell Carcinoma |
1.6% |
| Antiallergic Therapy |
1.2% |
| Dyslipidaemia |
1.2% |
| Headache |
1.2% |
|
| Completed Suicide |
12.8% |
| Death |
12.8% |
| Drug Interaction |
10.5% |
| Hypertensive Crisis |
5.8% |
| Unresponsive To Stimuli |
5.8% |
| Hypoglycaemia |
4.7% |
| Hypotension |
4.7% |
| Toxicity To Various Agents |
4.7% |
| Asthma |
3.5% |
| Atrial Fibrillation |
3.5% |
| Blood Pressure Decreased |
3.5% |
| Cardiac Arrest |
3.5% |
| Cardiogenic Shock |
3.5% |
| Drug Ineffective |
3.5% |
| Hyperkalaemia |
3.5% |
| Hypertension |
3.5% |
| Weight Decreased |
3.5% |
| Accelerated Idioventricular Rhythm |
2.3% |
| Asthenia |
2.3% |
| Blood Glucose Increased |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
34.4% |
| Hypertension |
10.2% |
| Migraine |
6.4% |
| Completed Suicide |
5.7% |
| Tracheobronchitis |
5.1% |
| Accidental Exposure |
4.5% |
| Atrial Fibrillation |
3.8% |
| Drug Use For Unknown Indication |
3.8% |
| Fusarium Infection |
3.8% |
| Epilepsy |
2.5% |
| Fluid Retention |
2.5% |
| Maternal Exposure During Pregnancy |
2.5% |
| Abdominal Pain Upper |
1.9% |
| Ascites |
1.9% |
| Basedow's Disease |
1.9% |
| Essential Tremor |
1.9% |
| Nerve Injury |
1.9% |
| Smoking Cessation Therapy |
1.9% |
| Tremor |
1.9% |
| Anxiety |
1.3% |
|
| Blood Pressure Fluctuation |
17.4% |
| Completed Suicide |
10.9% |
| Atrial Fibrillation |
8.7% |
| Cardiac Arrest |
6.5% |
| Drug Interaction |
6.5% |
| Respiratory Arrest |
6.5% |
| Ventricular Septal Defect |
6.5% |
| Death |
4.3% |
| Hypotension |
4.3% |
| Overdose |
4.3% |
| Painful Erection |
4.3% |
| Accidental Exposure |
2.2% |
| Areflexia |
2.2% |
| Balance Disorder |
2.2% |
| Capillary Nail Refill Test Abnormal |
2.2% |
| Cardiogenic Shock |
2.2% |
| Cerebrovascular Accident |
2.2% |
| Cyanosis |
2.2% |
| Depressed Level Of Consciousness |
2.2% |
| Drug Dose Omission |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.3% |
| Hepatitis C |
7.9% |
| Migraine |
7.5% |
| Sleep Disorder |
7.0% |
| Drug Use For Unknown Indication |
6.8% |
| Hypertension |
5.4% |
| Depression |
4.5% |
| Acute Lymphocytic Leukaemia |
4.1% |
| Anxiety |
3.6% |
| Nausea |
3.6% |
| Pain |
3.6% |
| Asthma |
3.4% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Hepatic Neoplasm Malignant |
3.2% |
| Ascites |
2.7% |
| Muscle Spasms |
2.7% |
| Type 2 Diabetes Mellitus |
2.7% |
| Insomnia |
2.3% |
| Prophylaxis |
2.3% |
| Osteoporosis |
2.0% |
|
| Ventricular Septal Defect |
19.7% |
| Vomiting |
10.6% |
| Hepatic Encephalopathy |
7.6% |
| Weight Increased |
6.1% |
| Aspartate Aminotransferase Increased |
4.5% |
| Asthenia |
4.5% |
| Fatigue |
4.5% |
| Squamous Cell Carcinoma Of Skin |
4.5% |
| Weight Decreased |
4.5% |
| Arthralgia |
3.0% |
| Death |
3.0% |
| Drug Eruption |
3.0% |
| Drug Ineffective |
3.0% |
| Muscular Weakness |
3.0% |
| Oedema Peripheral |
3.0% |
| Overdose |
3.0% |
| Pain |
3.0% |
| Platelet Count Decreased |
3.0% |
| Pulmonary Embolism |
3.0% |
| Tenosynovitis |
3.0% |
|
| Interacting |
|
| Hypertensive Crisis |
50.0% |
| Drug Interaction |
25.0% |
| Heart Rate Decreased |
25.0% |
|
